In this presentation from the 2016 US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, held August 26-27 in Alexandria, VA, Dr. Mark Heaney discusses the updated WHO diagnostic criteria for essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF).
The WHO Updated Diagnostic Criteria for ET, PV & MF
